Resources
-
Setting Specifications for Autologous CAR-T Cell Products
Roundtable Notes: Session 1 Table 6 CGTP 2025
Setting Specifications for Autologous CAR-T Cell Products -
Global Health in Cell and Gene Therapy
Roundtable Notes: Session 2 Table 10 CGTP 2025
Global Health in Cell and Gene Therapy -
Cost Drivers
Roundtable Notes: Session 2 Table 7 CGTP 2025
Cost Drivers -
Non-Traditional Approaches to Comparability (Session 2)
Roundtable Notes: Session 2 Table 3 CGTP 2025
Non-Traditional Approaches to Comparability (Session 2) -
Potency Assurance Strategies
Roundtable Notes: Session 2 Table 1 CGTP 2025
Potency Assurance Strategies -
Phase Appropriate Engineering Run Approaches and Stability
Roundtable Notes: Session 2 Table 5 CGTP 2025
Phase Appropriate Engineering Run Approaches and Stability -
Multiplex Approaches to Analytical Platforms for CGT Release
Roundtable Notes: Session 1 Table 4 CGTP 2025
Multiplex Approaches to Analytical Platforms for CGT Release -
Non-Traditional Approaches to Comparability
Roundtable Notes: Session 1 Table 3 CGTP 2025
Non-Traditional Approaches to Comparability -
Donor Selection Criteria Across ICH Regions
Roundtable Notes: Session 1 Table 2 CGTP 2025
Donor Selection Criteria Across ICH Regions -
Potency Assurance Strategies for Cell and Gene Therapies
Roundtable Notes: Session 1 Table 1 CGTP 2025
Potency Assurance Strategies for Cell and Gene Therapies -
Ensuring Product Comparability in Cell Therapy: Approach to Managing Multifactorial Changes
Speaker Presentation: CGTP 2025
Sachamitr Patty, BlueRock Therapeutics LP, 2025 -
Challenges in Getting Genome Editing Medicines into the Clinic
Speaker Presentation: CGTP 2025
Ramsey Phillip, Sangamo Therapuetics, Inc., 2025 -
Transparency-Driven Partnerships for Shared Success – iPSC Journey
Speaker Presentation: CGTP 2025
Pedro Castanho Vaz, Catalent, 2025 -
Developing and Deploying N-of-1 Gene-Editing Therapies
Speaker Presentation: CGTP 2025
Musunuru Kiran, University of Pennsylvania, 2025 -
Investigating the Aggregation, Genome Release, and Self-Interactions of Adeno-Associated Virus Formulations
Speaker Presentation: CGTP 2025
Motabar Lily, University of Delaware, 2025 -
Considerations in Development, Characterization, and Commercialization of Platform Processes
Speaker Presentation: CGTP 2025
Madaras Stephen, Miltenyi Biotec, 2025 -
A Single, Ready-to-Use Kit for Fast, Comprehensive Analysis of Both Plasmid Topological Isoforms and Linear Sizing on a Multi-Capillary Electrophoresis Platform
Speaker Presentation: CGTP 2025
Li Tingting, SCIEX, Kang Henry, SCIEX, 2025 -
Healthy Donor Cells Compared to SCD and TDT Patient Cells in Casgevy Process: Performance and Product Quality
Speaker Presentation: CGTP 2025
Kadiyala Irina, Vertex Pharmaceuticals Incorporated, 2025 -
ATMP Activities at MEB
Speaker Presentation: CGTP 2025
Hoefnagel Marcel, Medicines Evaluation Board, 2025 -
INS1203: RNA-End Joining Technology Enables A Dual AAV Approach for ABCA4 Gene Replacement in Stargardt Disease
Speaker Presentation: CGTP 2025
Hilde Kathryn, Insmed Incorporated, 2025